Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor

Jessica Shantha, Ian Crozier, Jay B. Varkey, Colleen S. Kraft, G Marshall Lyon III, Aneesh Mehta, Renee Donahue Carlson, Charles E. Hill, Gokul Kumar, Matthew R. Debiec, Purnima S. Patel, Timothy W. Olsen, Robert B. Nussenblatt, Daniel F. Martin, Ute Stroher, Timothy M. Uyeki, Bruce S. Ribner, Justine Smith, Steven Yeh

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)


The 2013–2016 West African Ebola virus (EBOV) disease (EVD) outbreak was the largest in history with 28 616 cases and 11 310 deaths in the highest transmission countries (Sierra Leone, Guinea, and Liberia).1 Reports of uveitis have emerged in EVD survivors.2, 3 We discuss clinical features, multimodality imaging, and long-term management of aggressive, sight-threatening panuveitis in an EVD survivor, providing insight into the pathogenesis of this condition.
Original languageEnglish
Pages (from-to)2626-2628.e2
Number of pages3
Issue number12
Publication statusPublished - 1 Dec 2016


  • vitreous inflammation
  • Ebola
  • heterochromia
  • conjunctival swab


Dive into the research topics of 'Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor'. Together they form a unique fingerprint.

Cite this